---
category: news
title: "CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences"
excerpt: "PRNewswire/ - CellCarta, a global provider of precision medicine services, announcedÂ today the acquisition of Reveal"
publishedDateTime: 2021-05-11T12:30:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-1030414541"
webUrl: "https://markets.businessinsider.com/news/stocks/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-1030414541"
type: article
quality: 27
heat: 27
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1507305/CellCarta_CellCarta_Strengthens_its_Histological_Biomarker_Franc.jpg"
    width: 373
    height: 400
    isCached: true

secured: "A2EbwTlCOAomSlenccCH66ZsuycKcWx8wR7j2pLl2RUaSKOljkPPtaAtQE8oGkPSV+fIdSuiA1CdfEWqJsWM2Oz72hHRkg0nR6E5v6uuWfVQan7sr58s7ULDFAvZYKhXmLtNqT89LqXVlQr2j+WCl1GgbVd1rPZ6J2Zhu8WUUuXoCs5RlGQWPb/0+EqkD55HDF5jjN5/3MBQjPnOVynQVXhFuQrwOwxdem1IYDN1PWme4Q4YPDlHfsIBoOvKTScOHv63nicbeZt8G4qjJ5NVG4NP5iJG2Vukqsy35PGKuLHUCX2B9cUwMgxlZzurem/PJQq9zYcItGMYA5m/cPasI5M98zX4th5igjpaZey/boM=;6+rdc/G9PyAs6sTy9M7KEw=="
---

